BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23359767)

  • 1. Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells.
    Liu KP; Luo F; Xie SM; Tang LJ; Chen MX; Wu XF; Zhong XY; Zhao T
    Chin J Cancer Res; 2012 Jun; 24(2):116-23. PubMed ID: 23359767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
    Luo F; Li J; Liu J; Liu K
    Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Liu K; Li J; Wu X; Chen M; Luo F; Li J
    Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
    Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGC-1α Regulates Cell Proliferation and Invasion
    Yun SH; Park JI
    Anticancer Res; 2020 Feb; 40(2):653-664. PubMed ID: 32014906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
    Rivest P; Renaud M; Sanderson JT
    Chem Biol Interact; 2011 Feb; 189(3):177-85. PubMed ID: 21111724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of GOLPH3 Gene with Wnt Signaling Pathway in Human Colon Cancer Cells.
    Qiu CZ; Wang MZ; Yu WS; Guo YT; Wang CX; Yang XF
    J Cancer; 2016; 7(8):928-34. PubMed ID: 27313783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells.
    Xie B; Li L; Zhang Z; Zhao L; Cheng J; Zhou C; Cheng J; Yan J; Chen J; Yi J; Wang B; Jin S; Wei H
    J Cancer; 2021; 12(14):4196-4208. PubMed ID: 34093820
    [No Abstract]   [Full Text] [Related]  

  • 12. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dexmedetomidine-mediated Wnt Pathway Inhibits Sevoflurane-induced Cognitive Impairment in Neonatal Rats].
    Yang Y; Yang L; Wu Y; Yuan J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):235-246. PubMed ID: 33966704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TNF-α activates PI3K/AKT pathway to promote proliferation of SW620
    Dai L; Zhao X; Ma L; Li X; Zuo D; Li Y; Wei B; Sui Y; Xu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):33-41. PubMed ID: 32314722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
    Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
    J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
    Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
    APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
    Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
    Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL; Liang S; Cui JH; Han GY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells.
    Min HJ; Koh SS; Cho IR; Srisuttee R; Park EH; Jhun BH; Kim YG; Oh S; Kwak JE; Johnston RN; Chung YH
    Int J Oncol; 2009 Sep; 35(3):617-24. PubMed ID: 19639182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.